For a triple-receptor agonist that targets GLP-1 , GIP, and glucagon receptors simultaneously, the neurological ripple effects are still being studied, still being understood
The effect of GLP-1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta-analysis Deanfield, et al
Some doctors estimate that as many as 10% of patients stopped using semaglutide medications like Ozempic due to these risks
GLP-1 users saw a 44% reduction in hospitalizations due to stroke, heart attack and heart failure compared to the control group
First, lack of exposure is possible, as we lacked information on patient compliance with prescribed treatments and potential lack of medication dispensed at hospitals, however as medication compliance is similar across all three groups and we defined exposure as redeemed prescriptions, ensuring that the medication was actively collected by the patient, systematic misclassification is unlikely
Yes, GLP-1 medications like Semaglutide and Tirzepatide require a prescription, which is provided after a medical consultation at Majestic Aesthetics
